GSP Crop Science

Why is GSP Crop Science Ltd falling/rising?

As of 30-Aug, GSP Crop Science Ltd's stock price is rising to 627.50, driven by strong performance against the Sensex and increased investor interest. The company’s net-debt-free status and solid financial metrics, including a 23% profit increase, further bolster its positive outlook.

As of 30-Aug, GSP Crop Science Ltd's stock price is rising, currently at 627.50, reflecting a change of 2.15 (0.34%) upward. This increase can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 5.49% compared to the Sensex's decline of 0.36%. Additionally, in the last month, the stock has risen by 14.70, while the Sensex has only increased by 0.65%. <BR><BR>Despite experiencing a decline of 2.88% over the last two days, the stock is trading above its moving averages across various time frames, indicating a generally positive trend. Furthermore, there has been a significant rise in investor participation, with delivery volume on August 27 increasing by 131.62% compared to the 5-day average, suggesting heightened interest in the stock. <BR><BR>The company's financial health also supports its rising stock price, as it is net-debt free and has an attractive valuation with a return on equity (ROE) of 12.7 and a price-to-book value of 4. Additionally, the company has seen a 23% increase in profits over the past year, further enhancing investor confidence. Overall, these factors contribute to the upward movement in GSP Crop Science Ltd's stock price.

Which are the latest news on GSP Crop Science?

Should I buy, sell or hold GSP Crop Science Ltd?

What does GSP Crop Science do?

GSP Crop Science Ltd is a small-cap company in the Pesticides & Agrochemicals industry, reporting net sales of 386 Cr and a net profit of 26 Cr for June 2026. It has a market cap of INR 2,740 Cr, a P/E ratio of 26.00, and a debt-equity ratio of 0.05.

Overview:<BR>GSP Crop Science Ltd operates in the Pesticides & Agrochemicals industry and is categorized as a Small Cap company.<BR><BR>History:<BR>The company was originally incorporated as "Gujarat Superphosphate Industries Private Limited" in 1985. It later changed its name to "GSP Crop Science Private Limited" in 2003. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 386 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 26 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 2,740 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 26.00 <BR>Industry P/E: 27 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.05 <BR>Return on Equity: 12.69% <BR>Price to Book: 3.74 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the GSP Crop Science?

GSP Crop Science's peers include Sharda Cropchem, Dhanuka Agritech, Rallis India, and others. Dhanuka Agritech shows excellent management risk, while Bhagiradha Chem. has the highest 1-year return at -1.91%, and Rallis India has the lowest at -43.96%.

Peers: The peers of GSP Crop Science are Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., Bharat Rasayan, Insecticid.India, India Pesticides, Meghmani Organi., Astec Lifescienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dhanuka Agritech, while Average management risk is found at Sharda Cropchem, Rallis India, NACL Industries, Bhagiradha Chem., Bharat Rasayan, Insecticid.India, and India Pesticides, and the rest. Growth is rated as Good for Sharda Cropchem, while Below Average growth is noted for Dhanuka Agritech, Rallis India, NACL Industries, and the rest. In terms of Capital Structure, Excellent ratings are given to Dhanuka Agritech, Rallis India, Bharat Rasayan, Insecticid.India, and India Pesticides, while Good is noted for Bhagiradha Chem., and the rest have Below Average or Average ratings.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bhagiradha Chem. at -1.91%, while Rallis India has the lowest at -43.96%. GSP Crop Science's 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include Rallis India, Bharat Rasayan, Astec Lifescienc, and India Pesticides.

How big is GSP Crop Science?

As of 14th August, GSP Crop Science Ltd has a market capitalization of 2,785.00 Cr, with recent net sales of 1,526.11 Cr and a net profit of 100.79 Cr. Shareholder's funds are 450.04 Cr, and total assets amount to 1,206.10 Cr.

As of 14th August, GSP Crop Science Ltd has a market capitalization of 2,785.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, GSP Crop Science reported Net Sales of 1,526.11 Cr and a Net Profit of 100.79 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 450.04 Cr and Total Assets of 1,206.10 Cr.

When is the next results date for GSP Crop Science Ltd?

The next results date for GSP Crop Science Ltd is 11 August 2026.

The next results date for GSP Crop Science Ltd is scheduled for 11 August 2026.

Are GSP Crop Science Ltd latest results good or bad?

GSP Crop Science Ltd's latest results show strong revenue growth with a consolidated net profit of ₹20.48 crores for Q4 FY26, a significant improvement from the previous quarter. However, net profit is down 9.62% year-on-year, and declining margins raise concerns about operational efficiency and reliance on non-operating income, suggesting investors should proceed with caution.

GSP Crop Science Ltd's latest results present a mixed picture. On the positive side, the company reported a consolidated net profit of ₹20.48 crores for Q4 FY26, marking a significant turnaround from a loss in the previous quarter and showing a substantial sequential growth of 481.38%. Additionally, net sales surged by 45.85% year-on-year and 48.87% quarter-on-quarter, reaching ₹402.47 crores, which reflects strong demand in the agrochemical sector.<BR><BR>However, the results also reveal significant challenges. The net profit is down 9.62% compared to the same quarter last year, despite the higher revenue, indicating issues with operational efficiency. Operating margins have compressed to 9.02%, down from 12.89% year-on-year, suggesting that rising costs are impacting profitability. Furthermore, the profit margins are concerning, with a PAT margin of just 4.88%, down from 7.07% a year ago.<BR><BR>Another red flag is the company's reliance on other income, which constituted 32.41% of profit before tax in Q4 FY26, raising questions about the sustainability of its core business profitability. <BR><BR>In summary, while GSP Crop Science has shown impressive revenue growth and a recovery in profits compared to the previous quarter, the decline in margins and dependence on non-operating income highlight ongoing operational challenges. Investors should be cautious and monitor future performance closely to assess whether these issues can be addressed effectively.